Table 5. The observed improvement in total and subscales of the FIQ score from baseline to Week 8 in each group .
|
FIQ Score |
Week 8 minus week 0 Group A (Trazodone + Vit D) (n = 37) |
p* |
Week 8 minus week 0 Group B (Trazodone + Placebo) (n = 37) |
p* |
| Total score | -23.68 ± 18.58 | 0.002 | -10.27 ± 17.13 | 0.002 |
| Work | -2.34 ± 4.24 | 0.004 | -1.61 ± 2.84 | 0.072 |
| Pain | -1.65 ± 3.37 | 0.0001 | -0.91 ± 0.96 | 0.023 |
| Fatigue | -2.81 ± 3.27 | 0.0001 | -1.36 ± 3.42 | 0.053 |
| Morning tiredness | -3.65 ± 3.40 | 0.0001 | -1.27 ± 3.91 | 0.026 |
| Stiffness | -3.18 ± 3.36 | 0.0001 | -1.22 ± 3.15 | 0.01 |
| Anxiety | -3.55 ± 3.10 | 0.0001 | -1.50 ± 3.29 | 0.238 |
| Depression | -3.21 ± 4.16 | 0.0001 | -0.75 ± 3.74 | 0.001 |
Results are presented as mean ± SD
*Within group’s comparison by paired t test